Core Insights - HRC World Plc reported a significant increase in revenue for the financial year ending 31 March 2025, reaching US$818,000 compared to US$141,000 in the previous year, indicating a successful strategic realignment [2] - The company narrowed its pre-tax loss to US$46,000 from US$220,000 in the prior year, showcasing improved operational cost control while investing in future growth sectors [2] - The company is optimistic about its strategic direction, focusing on digital infrastructure and sustainable energy solutions, while gradually shifting from restaurant management services to technology-driven business segments [3] Financial Performance - Revenue for the year ending 31 March 2025 was US$818,000, a substantial increase from US$141,000 in the previous year [2] - Pre-tax loss decreased to US$46,000 from US$220,000, reflecting better cost management [2] Strategic Direction - The company is advancing its strategic transformation towards digital infrastructure and sustainable energy solutions [3] - There is a shift in focus from restaurant management services to the development of data centre and IT infrastructure capabilities [3] Dividend Policy - The Directors have decided not to propose the payment of a dividend [4]

CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- TSX-V: CWV: Crown Point Energy Inc. ("Crown Point", the "Company” or "we") announces that Gabriel Obrador has resigned as the President, CEO and a director of the Company and its subsidiaries effective today to pursue other opportunities. The Board of Directors of Crown Point has commenced a search process to identify a qualified candidate to replace Mr. Obrador. In the interim, Marisa Tormakh, the VP, Finance and CFO of the Company and Hermann Steinbuch, ...

Group 1 - Canacol Energy Ltd. will announce its second quarter 2025 financial results on August 7, 2025, after market closure [1] - A conference call to discuss the results is scheduled for August 8, 2025, at 8:00 a.m. MT / 10:00 a.m. ET [1] - The financial results will be accessible through the Investor Relations section of the company's website, with a replay available until August 18, 2025 [2] Group 2 - Canacol is a natural gas exploration and production company primarily operating in Colombia [3] - The company's common stock is traded on the Toronto Stock Exchange, OTCQX in the USA, and the Colombia Stock Exchange under ticker symbols CNE, CNNEF, and CNEC respectively [3]

Core Viewpoint - Altai Resources Inc. is seeking shareholder approval for a special resolution to reduce the stated capital account of its common shares by up to $4,000,000 for the purpose of distributing this amount as a return of capital through special cash distributions [1]. Group 1: Company Announcement - The company has filed a management information circular and related meeting materials for a special meeting of shareholders scheduled for September 3, 2025 [1]. - The proposed capital reduction will allow for cash distributions to holders of common shares [1]. Group 2: Shareholder Information - Shareholders are encouraged to review the Meeting Materials, which are available on SEDAR+ and will be mailed to eligible shareholders [2]. Group 3: Company Overview - Altai Resources Inc. is based in Toronto, Ontario, and has a producing oil property in Alberta, an exploration gold property in Quebec, and a Canadian investment portfolio consisting of cash and cash equivalents [3].

TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- European Residential Real Estate Investment Trust (“ERES” or the “REIT”) (TSX:ERE.UN) announced today an update on the expected timing of its previously disclosed disposition, and its anticipated special distribution, as disclosed in its press release dated April 2, 2025. ERES also announced approximately €52.8 million in additional strategic dispositions, and an intention to cease its regular monthly distributions. All amounts disclosed herein exclude transaction ...

VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (“Eldorado” or “the Company”) announces that it has received approval from the Toronto Stock Exchange (the "TSX") of Eldorado’s notice of intention to renew its normal course issuer bid (the "NCIB"). Pursuant to the NCIB, Eldorado may purchase up to 10,159,967 common shares of Eldorado ("Common Shares"), which is 5% of the 203,199,350 issued and outstanding Common Shares as at July 30, 2025. Purchases will be made throu ...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES (Note: All dollar amounts in this press release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from unaudited financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board ("IFRS® Accounting Standards"), except as otherwise noted. This press release contains ...

Core Viewpoint - Pacific Health Care Organization, Inc. reported significant financial growth in its quarterly results for the period ending June 30, 2025, indicating improved operational efficiency and profitability compared to the same period in the previous year [1][2][3]. Financial Performance - Total revenues for the quarter ended June 30, 2025, were $1,726,541, an increase from $1,541,087 for the same quarter in 2024, reflecting a year-over-year growth of approximately 12% [2]. - Income from operations rose to $303,559 for the quarter ended June 30, 2025, compared to $191,995 for the same quarter in 2024, marking an increase of about 58% [2]. - Net income for the quarter was $636,907, or $0.05 per weighted average share, compared to $215,556, or $0.02 per share, for the same quarter in 2024, representing a substantial increase in profitability [3]. Cash Flow Analysis - Net cash provided by operating activities for the six months ended June 30, 2025, was $785,838, a significant increase of $642,190 compared to $143,648 for the same period in 2024 [3]. - Net cash used in investing activities was ($664,536) for the six months ended June 30, 2025, compared to ($181,963) for the same period in 2024, primarily due to the purchase of US Treasury Bills [4]. - Net cash used in financing activities was $35,930 for the six months ended June 30, 2025, a shift from $105,915 of cash provided by financing activities during the same period in 2024, attributed to the maturation of an insurance financing agreement [5]. Company Overview - Pacific Health Care Organization, Inc. specializes in workers' compensation cost containment, aiming to reduce medical claims expenses while ensuring high-quality healthcare for injured employees [7]. - The company offers a range of services, including Health Care Organizations, Medical Provider Networks, medical case management, utilization review, medical bill review, and Medicare set-aside services, which can be provided as bundled solutions or standalone services [7].

Core Viewpoint - Arhaus, Inc. is set to release its second quarter 2025 financial results on August 7, 2025, before the market opens, followed by a conference call to discuss these results [1] Company Overview - Arhaus, founded in 1986, is a lifestyle brand and omni-channel retailer specializing in premium artisan-crafted home furnishings [3] - The company employs a proprietary model that involves direct design and sourcing from leading manufacturers and artisans globally, offering heirloom quality products that are sustainably sourced and built to last [3] - Arhaus operates over 100 showroom and design studio locations across the United States and provides complimentary in-home design services through a team of interior designers [3] - The company is recognized for its innovative design, responsible sourcing, and client-first service [3] Investor Communication - A live webcast of the upcoming conference call will be available at ir.arhaus.com, with participation options provided for both U.S. and international callers [2] - A telephone replay of the call will be accessible for one week, and a webcast replay will be available for approximately 12 months [2]

Financial Results Announcement - Coherus Oncology will release its second quarter 2025 financial results after market close on August 7, 2025 [1] - A conference call and webcast will be hosted by Coherus' management team starting at 5:00 p.m. EDT on the same day to discuss the financial results and provide a business update [1][3] Webcast and Access Information - A replay of the webcast will be available on the Coherus investor website following the live conference call [2] - The press release with the financial results and related materials will be accessible on the investor website before the conference call begins [3] Company Overview - Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved PD-1 inhibitor, LOQTORZI, and a promising pipeline including two mid-stage clinical candidates targeting various cancers [6] - The company aims to grow sales of LOQTORZI in nasopharyngeal carcinoma and advance new indications in combination with pipeline candidates and partners [6] Pipeline and Research Focus - Coherus' pipeline includes multiple antibody immunotherapy candidates designed to enhance immune responses against tumors [7] - CHS-114, a selective anti-CCR8 antibody, is in Phase 1b studies for advanced solid tumors, while Casdozokitug, an IL-27 antagonistic antibody, is being evaluated in multiple studies for various cancers [7]